Member Info for adamk87

Added 750k - buy not showing on trades. Only a matter of time before we rerate. Patience needed

Took some @ 15.

GL

Well said Dev and massive congrats on holding 7m of these. Im at 2m myself and believe these will be worth well north of 5p end of Q1 2020. Happy to hold and wait.

Some people dont realise how much Woodford selling affected the SP here, believing it is where it is on merit. FDA approved, other failed approvals (like mtfb which fell from 40p to 0.50 currently due to domino effect of having their fda approval declined/delayed).

At worst we get bought out next year above 5p and thats a given. Building a holding of 7m at these prices is the best gift anyone could give you going into 2020, believe that.

GL

Wow very nice! Took some on the rns at 15p and exited within 30 minutes. 3k profit banked in less than 30 minutes very happy with that. GL holders

Black Friday sales!!! Hence the heading lol

Actual bid v ask is 2.45 - 2.50

Maybe this is the bottom.

Took 50k - will add more on a dip or rise as god knows what the mm’s are up too.

I think they’ve been in auto pilot with ii selling taking the bid down to take theirs as cheaply as possible and havent woken from their slumber. They will do soon but judging by price action im not sure whether it moves up or down.

After doing some research, very happy buying this at 2.5p however if it dips more a part of me would be happier as it would allow me to add a substantial amount. Within 6-8 weeks can see this being back up around 7p mark once grant funding arrives.

Shenanigans of aim eh! GL

It doesnt quite look finished here, happy to add just reluctant given price action (then theres the chance it could get taken up quickly).

Mm’s are playing this, which im ok with if it means adding a decent chunk at a good price, i thought 2.79 was a good entry price yesterday (which it is) however the mm’s look to be singing off a different hymn sheet here.

A rollover then.

The 10.5m ‘buy’s - within a minute of one another. Definitely a bed and isa transaction.

Looks like a bed and isa to me.

Patience is a virtue, easy hold and those that cant ought to lose a few quid. Xmas sales early here. GL

I thought black Friday was last week? Looks like we have a sale on this week too

EAL - thanks for sharing.

It was indeed great news and its good to see the guys at Midatech are as perplexed as we are re share price.

I believe the mm’s took advantage of the afternoon rns with eyes elsewhere and played on the sales. They would take all of my (modest) holdings in one go above bid all afternoon once they bought the bid down to 2.7.

They will let it go at some point in the very near future and until the sub 3p is a bargain given recent news flow by way of rns including the number of director buys recently above 5-6p.

I’l be adding in the morning and throughout next week around the 3p range. GL

Decent day, more 20% days ahead thats for sure.

As much as i also dislike tr1 talks (especially those forecasting when it will arrive) so many delayed trades today, this week and the past few weeks a number of these are due.

GL

Nice buy after close.

Midatech (AIM: MTPH.L; NASDAQ: MTP), the R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 450,000 ordinary shares of 0.005 pence each in the Company ("Share(s)") at a price of 6.75 pence per Share.

-

Midatech (AIM: MTPH.L; NASDAQ: MTP), the R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 100,000 ordinary shares of 0.005 pence each in the Company ("Share(s)") at a price of 5.89 pence per Share.

-

Midatech (AIM: MTPH.L; NASDAQ: MTP), the R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 250,000 ordinary shares of 0.005 pence each in the Company ("Share(s)") at a price of 5.5 pence per Share.

-

Midatech (AIM: MTPH.L; NASDAQ: MTP), the R&D biotechnology company focused on delivering innovative oncology and rare disease products to patients, announces that Stephen Stamp, Chief Financial Officer and a Director of the Company, has purchased 200,000 ordinary shares of 0.005 pence each in the Company ("Share(s)") at a price of 5.35 pence per Share.

-

If they were happy paying 6p or there abouts only 2 months ago, im more than happy to buy sub 3p and hold onto these.

Took some at 2.79. Bargain on offer everywhere on aim it seems. GL

Yes, a good buying opportunity if you pass up sub 3p. GL

One of these pushes will break 1.3 and when it does its clear skies. Strong buy and hold. GL

Applegarth - its in the Dormammu time loop